|Acceleron speaker:||John Knopf, Ph.D., Chief Executive Officer of Acceleron|
|Date:||Tuesday, December 3, 2013|
|Time:||3:00 PM (EST)|
|Location:||New York Palace Hotel, New York, NY|
There's little to substantiate the president-elect's claim that he will bring drug prices down, but biotech investors are trading anyway.
I spent the weekend with thousands of blood disease researchers. This is what happened.
While a phase III study progresses, Acceleron is searching for different populations of MDS patients where luspatercept might also be effective.